These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9519748)

  • 1. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
    Gilbert RE; Cox A; Wu LL; Allen TJ; Hulthen UL; Jerums G; Cooper ME
    Diabetes; 1998 Mar; 47(3):414-22. PubMed ID: 9519748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy.
    Rumble JR; Gilbert RE; Cox A; Wu L; Cooper ME
    J Hypertens; 1998 Nov; 16(11):1603-9. PubMed ID: 9856360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
    Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
    J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
    Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
    Park IS; Kiyomoto H; Abboud SL; Abboud HE
    Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats.
    Li C; Yang CW; Park CW; Ahn HJ; Kim WY; Yoon KH; Suh SH; Lim SW; Cha JH; Kim YS; Kim J; Chang YS; Bang BK
    Kidney Int; 2003 Feb; 63(2):454-63. PubMed ID: 12631111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.
    Gilbert RE; Wilkinson-Berka JL; Johnson DW; Cox A; Soulis T; Wu LL; Kelly DJ; Jerums G; Pollock CA; Cooper ME
    Kidney Int; 1998 Oct; 54(4):1052-62. PubMed ID: 9767521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Arginine treatment may prevent tubulointerstitial nephropathy caused by germanium dioxide.
    Yanagisawa H; Yamazaki N; Sato G; Wada O
    Kidney Int; 2000 Jun; 57(6):2275-84. PubMed ID: 10844598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.
    Tikellis C; Johnston CI; Forbes JM; Burns WC; Burrell LM; Risvanis J; Cooper ME
    Hypertension; 2003 Mar; 41(3):392-7. PubMed ID: 12623933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.
    Wiggins KJ; Tiauw V; Zhang Y; Gilbert RE; Langham RG; Kelly DJ
    Nephrology (Carlton); 2008 Dec; 13(8):721-9. PubMed ID: 18826488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
    Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
    Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
    Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced tubular cation transport in diabetes: prevented by ACE inhibition.
    Thomas MC; Tikellis C; Burns WC; Thallas V; Forbes JM; Cao Z; Osicka TM; Russo LM; Jerums G; Ghabrial H; Cooper ME; Kantharidis P
    Kidney Int; 2003 Jun; 63(6):2152-61. PubMed ID: 12753302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.
    Benigni A; Zoja C; Corna D; Zatelli C; Conti S; Campana M; Gagliardini E; Rottoli D; Zanchi C; Abbate M; Ledbetter S; Remuzzi G
    J Am Soc Nephrol; 2003 Jul; 14(7):1816-24. PubMed ID: 12819241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.